The primary endpoint of resolution of MASH without worsening of fibrosis was achieved in 40%, 36%, 59%, and 17% of participants in the 0.1, 0.2, 0.4 mg, and placebo groups, respectively ( p 90%) were mild to moderate in severity
Outpatient Sedation Basics for Patients on GLP-1 Medications: What Non-Anesthesiologists Need to Know With more patients taking GLP-1 medications like Ozempic, Wegovy, or Trulicity for diabetes and weight loss, it's important for all providersdentists, proceduralists, and specialists who give sedation outside of operating roomsto understand how these drugs can affect their procedures.pubmed.ncbi.nlm
Can we use old NAFLD data under the new MASLD definition
Note: The semaglutide prescribed through our program is FDA-approved for other uses, but not specifically as a weight loss medication, similar to others in its class